↓ Skip to main content

Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck

Overview of attention for article published in Investigational New Drugs, November 2007
Altmetric Badge

Mentioned by

patent
22 patents

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
33 Mendeley
Title
Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
Published in
Investigational New Drugs, November 2007
DOI 10.1007/s10637-007-9098-8
Pubmed ID
Authors

Patricia A. Tang, Lillian L. Siu, Eric X. Chen, Sebastien J. Hotte, Stephen Chia, James K. Schwarz, Gregory R. Pond, Caitlin Johnson, A. Dimitrios Colevas, Timothy W. Synold, Lakshmi S. Vasist, Eric Winquist

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 27%
Researcher 6 18%
Student > Master 5 15%
Other 4 12%
Student > Bachelor 2 6%
Other 3 9%
Unknown 4 12%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 21%
Agricultural and Biological Sciences 7 21%
Medicine and Dentistry 6 18%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Chemistry 2 6%
Other 2 6%
Unknown 7 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#7,720,531
of 23,477,147 outputs
Outputs from Investigational New Drugs
#341
of 1,193 outputs
Outputs of similar age
#41,912
of 159,316 outputs
Outputs of similar age from Investigational New Drugs
#2
of 5 outputs
Altmetric has tracked 23,477,147 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,193 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,316 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.